Company news

Correvio Pharma Corp news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Cardiome Expands Partnership with Eddingpharm to Commercialize AGGRASTAT in China

August 24, 2015

United Kingdom Department of Health Sets BRINAVESS Pricing

August 10, 2015

Cardiome Reports Second Quarter 2015 Financial Results

August 5, 2015

Cardiome to Hold Second Quarter 2015 Financial Results Conference Call on August 5

July 28, 2015

Cardiome Partner Eddingpharm to Initiate BRINAVESS Phase I Study in China

July 24, 2015

Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

July 22, 2015

Cardiome to Present at JMP Securities Healthcare Conference

June 16, 2015

Independent Study Finds Intravenous Vernakalant Facilitates Electrical Cardioversion in Patients with Cardioversion Resistant Atrial Fibrillation

June 12, 2015

Cardiome Appoints David Dean Vice President, Business Development and Investor Relations

June 3, 2015

Cardiome Reports First Quarter 2015 Financial Results

May 13, 2015

Cardiome and AOP Orphan Pharma Enter ESMOCARD Commercialization Agreement

May 12, 2015

Cardiome To Hold First Quarter 2015 Financial Results Conference Call On May 13

May 7, 2015

Cardiome to Present at Bloom Burton & Co. Healthcare Investor Conference

April 27, 2015

Cardiome Receives BRINAVESS Reimbursement Approval From Belgian Authorities

April 9, 2015

Cardiome reports fourth quarter and full year 2014 financial results

March 12, 2015

Cardiome to Hold Fourth Quarter and Full Year 2014 Financial Results Conference Call on March 12

March 5, 2015

Cardiome Enters Development and Commercialization Agreement with Eddingpharm for BRINAVESS(TM) in China

December 19, 2014

Cardiome Enters Commercialization Agreement with Aspen for BRINAVESS® in South Africa

November 17, 2014

Cardiome Submits BRINAVESS® Reimbursement Dossier to Italian Authorities to Support Market Access

November 7, 2014

Cardiome Reports Third Quarter 2014 Financial Results

November 7, 2014

Cardiome Announces Positive Results from the BRINAVESS® Asia-Pacific Phase 3 Clinical Trial

November 7, 2014

Cardiome to Hold Third Quarter 2014 Financial Results Conference Call on November 7

October 31, 2014

S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices

September 12, 2014

Cardiome Enters Commercialization Agreement With Eurolab Especialidades Medicinales For BRINAVESS(TM) In Argentina

August 25, 2014

Cardiome Reports Second Quarter 2014 Financial Results

August 11, 2014

Cardiome Submits BRINAVESS Dossier to French Authorities to Support Market Access

August 6, 2014

Cardiome To Present At Canaccord Genuity Growth Conference On August 13

August 6, 2014

Cardiome Submits BRINAVESS Reimbursement Dossier to Belgian Authorities

August 5, 2014

Cardiome to hold second quarter 2014 financial results conference call on August 11

August 5, 2014

Cardiome announces closing of senior, secured term loan facility

July 18, 2014

Cardiome to Present at JMP Securities Healthcare Investor Conference

June 19, 2014

Cardiome to present at Bloom Burton & Co. Healthcare Investor Conference

June 11, 2014

Cardiome Announces Commercialization Partnership For AGGRASTAT® In Select European Markets

May 20, 2014

Cardiome Reports First Quarter 2014 Financial Results

May 12, 2014

Cardiome to hold first quarter 2014 financial results conference call on May 12

May 6, 2014

Cardiome Announces Commercialization Agreement With UDG Healthcare plc For BRINAVESS(TM) In Ireland

May 5, 2014

Cardiome Enters Agreement With Vianex S.A. To Commercialize BRINAVESS In Greece

March 28, 2014

Cardiome Reports Fourth Quarter and Full Year 2013 Financial Results

March 27, 2014

Cardiome To Hold Fourth Quarter And Full Year 2013 Financial Results Conference Call On March 27

March 20, 2014

Cardiome Enters Into an Agreement to Distribute BRINAVESS in Spain

March 19, 2014

Cardiome Closes C$30 Million Primary And Secondary Common Share Offering

March 11, 2014

Cardiome Announces C$30 Million Primary and Secondary Common Share Offering

February 20, 2014

Cardiome Announces Update in Commercialization Partnership for BRINAVESS(TM) in Select European Markets

February 19, 2014

Cardiome Enters BRINAVESS Distribution Agreement With Nomeco A/S In Denmark

February 18, 2014

Cardiome Announces At-The-Market Offering

February 18, 2014

Cardiome's BRINAVESS Demonstrates 74% Cardioversion in Post-Cardiac Surgery Patients with Atrial Fibrillation

February 13, 2014

Cardiome Enters Brinavess Distribution Agreement with Tamro AB in Sweden

February 11, 2014

Cardiome Announces Filing Of Shelf Prospectus And Registration Statement

January 30, 2014

Europace Publishes Data Supporting Use Of BRINAVESS(TM) (Vernakalant) As A First Line Agent For Pharmacological Cardioversion Of Atrial Fibrillation

November 21, 2013

Cardiome To Acquire Correvio LLC

November 18, 2013

← Newer news releases · Older news releases →

Decks